AWM Investment Company’s Satellos Bioscience MSLE Stock Holding History

AWM Investment Company’s Portfolio MSLE Stock Details MSLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Buy	+180,000	New	+$1.24M	0.12%	92

Other funds holding MSLE

Franklin Resources

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

AWM Investment Company's MSLE Position: Q2 2026 in Review

AWM Investment Company opened a new position in Satellos Bioscience (MSLE) in Q2 2026: 180,000 shares worth $1.4M. The stake represents 0.12% of the portfolio and ranks #92 among its holdings.

26 funds tracked by Wall St. Rank hold MSLE as of Q2 2026.

AWM Investment Company held 180,000 shares of Satellos Bioscience worth $1.4M as of Q2 2026.
Satellos Bioscience was a new AWM Investment Company position in Q2 2026.
Satellos Bioscience made up 0.12% of AWM Investment Company's portfolio in Q2 2026, its #92 holding.
26 funds tracked by Wall St. Rank held Satellos Bioscience as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.